Application of SELDI-TOF inN-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer

Identification of O-glycosylated Proteins That Are Aberrantly Excreted in the Urine of Patients with Early Stage Ovarian Cancer

(2013) Alan Mu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Detection of Differential Levels of Proteins in the Urine of Patients with Endometrial Cancer: Analysis Using Two-Dimensional Gel Electrophoresis and O-Glycan Binding Lectin

(2012) Alan Kang-Wai Mu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

(2012) Toon Van Gorp et al.   Proteome Science

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass

(2012) Wouter Wegdam et al.   Proteome Science

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology

(2010) Yi-Ting Chen et al.   JOURNAL OF PROTEOME RESEARCH

Serum Biomarkers for Early Detection of Gynecologic Cancers

(2010) Yutaka Ueda et al.   Cancers

Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma

(2009) Makiko Hoshino et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature

(2009) Digant Gupta et al.   Journal of Ovarian Research

Proteiomic patterns for endometrial cancer using SELDI-TOF-MS

(2008) Li-rong Zhu et al.   Journal of Zhejiang University-SCIENCE B